Brown Shipley & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Brown Shipley & Co's PFE Position: Q3 2026 in Review
Brown Shipley & Co reduced its Pfizer (PFE) stake by 4.8% in Q3 2026, selling an estimated $9.7K and leaving 7,167 shares worth $204K. The position accounts for 0.1% of the portfolio, ranked #41.
Brown Shipley & Co first reported a position in PFE in Q1 2023 and has held it in 15 quarters since. The position peaked at $839K in Q1 2023. 2,864 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Brown Shipley & Co held 7,167 shares of Pfizer worth $204K as of Q3 2026.
- Brown Shipley & Co sold 363 Pfizer shares in Q3 2026, an estimated $9.7K.
- Pfizer made up 0.1% of Brown Shipley & Co's portfolio in Q3 2026, its #41 holding.
- Brown Shipley & Co first reported a position in Pfizer in Q1 2023 and has held it in 15 quarters since.
- Brown Shipley & Co's Pfizer position peaked at $839K in Q1 2023.
- 2,864 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Brown Shipley & Co's 13F filing for Q3 2026, filed 9 Oct 2026.